Literature DB >> 12557753

Presence of variant transthyretin in aqueous humor of a patient with familial amyloidotic polyneuropathy after liver transplantation.

Katsuki Haraoka1, Yukio Ando, Eiko Ando, Xuguo Sun, Masaaki Nakamura, Hisayasu Terazaki, Shogo Misumi, Yutaka Tanoue, Takahiro Tajiri, Shozo Shoji, Takashi Ishizaki, Hiroaki Okabe, Hidenobu Tanihara.   

Abstract

To determine the origin of transthyretin (TTR) in the aqueous humor of patients with familial amyloidotic polyneuropathy (FAP), we measured TTR levels and analyzed the TTR forms in the aqueous humor of three FAP patients (one patient; liver transplanted, and two patients; non-transplanted). The total TTR levels were almost the same as reported previously in non-transplanted patients and slightly increased in a transplanted patient. Analyses with mass spectrometry in the two non-transplanted FAP ATTR V30M patients revealed that both wild type and variant TTR forms were detected in their aqueous humor samples. Moreover, variant TTR forms could be detected in the aqueous humor of the transplanted patient while the liver produced no variant TTR. These results suggest that variant TTR in aqueous humor may be derived from retina where TTR was produced. In conclusion, TTR metabolism may occur in its own ocular cycle and variant TTR produced by the retina may play an important role in amyloid formation in the ocular tissues of FAP patients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12557753     DOI: 10.3109/13506120209114101

Source DB:  PubMed          Journal:  Amyloid        ISSN: 1350-6129            Impact factor:   7.141


  5 in total

1.  Ophthalmological manifestations in hereditary transthyretin (ATTR V30M) carriers: a review of 513 cases.

Authors:  João Melo Beirão; Jorge Malheiro; Carolina Lemos; Idalina Beirão; Paulo Costa; Paulo Torres
Journal:  Amyloid       Date:  2015-06-22       Impact factor: 7.141

2.  Anterior Chamber Flare as an Objective and Quantitative Noninvasive Method for Oculopathy in Transthyretin V30M Amyloidosis Patients.

Authors:  João Beirão; Vasco Miranda; Beatriz Pinheiro-Torres; João Coelho; Maria-João Menéres; Pedro Menéres
Journal:  J Ophthalmol       Date:  2018-09-20       Impact factor: 1.909

Review 3.  Recent advances in transthyretin amyloidosis therapy.

Authors:  Mitsuharu Ueda; Yukio Ando
Journal:  Transl Neurodegener       Date:  2014-09-13       Impact factor: 8.014

Review 4.  Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithm.

Authors:  Yoshiki Sekijima; Mitsuharu Ueda; Haruki Koike; Sonoko Misawa; Tomonori Ishii; Yukio Ando
Journal:  Orphanet J Rare Dis       Date:  2018-01-17       Impact factor: 4.123

5.  De novo intraocular amyloid deposition after hepatic transplantation in familial amyloidotic polyneuropathy.

Authors:  Ivo Filipe Gama; Leonor Duarte Almeida
Journal:  World J Transplant       Date:  2017-08-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.